Literature DB >> 17223614

The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men.

Anne Saarinen1, Ville-Valtteri Välimäki, Matti J Välimäki, Eliisa Löyttyniemi, Kirsi Auro, Piia Uusen, Mairi Kuris, Anna-Elina Lehesjoki, Outi Mäkitie.   

Abstract

INTRODUCTION: Polymorphisms in the gene coding for low-density lipoprotein receptor-related protein 5 (LRP5) contribute to variation in bone mass in the general population. Whether this is due to influence on bone mass acquisition or on bone loss thereafter has not been established.
METHODS: We studied the association of LRP5 polymorphisms with peak bone mass in young men. The study included 235 Finnish men, aged 18.3 to 20.6 years. Lifestyle factors and fracture history were recorded. Bone mineral content (BMC), density (BMD) and scan area were measured for the lumbar spine and proximal femur by dual energy X-ray absorptiometry (DXA). Blood and urine were collected for determination of bone turnover markers, serum 25-OHD and PTH. Genomic DNA was extracted from peripheral blood for genetic analysis of LRP5. Ten single nucleotide polymorphisms in LRP5 were analyzed and correlated with bone parameters.
RESULTS: Only the A1330V polymorphism of LRP5 significantly associated with bone parameters. In comparison with subjects with the AlaAla genotype (n=215), those with AlaVal genotype (n=20) had lower femoral neck BMC (P=0.029) and BMD (P=0.012), trochanter BMC (P=0.0067) and BMD (P=0.015), and total hip BMC (P=0.0044) and BMD (P=0.0089). Fracture history was similar for the genotypes.
CONCLUSION: The polymorphic valine variant at position 1330 of LRP5 was significantly associated with reduced BMC and BMD values in healthy young Finnish men. The results provide evidence for the crucial role of LRP5 in peak bone mass acquisition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17223614     DOI: 10.1016/j.bone.2006.11.010

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  24 in total

Review 1.  LRP receptor family member associated bone disease.

Authors:  N Lara-Castillo; M L Johnson
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

Review 2.  Wnt signaling in bone development and disease: making stronger bone with Wnts.

Authors:  Jean B Regard; Zhendong Zhong; Bart O Williams; Yingzi Yang
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

3.  LRP5 and bone mass regulation: Where are we now?

Authors:  Mark L Johnson
Journal:  Bonekey Rep       Date:  2012-01-10

4.  A polymorphism near osteoprotegerin gene confer risk of obesity in Uyghurs.

Authors:  Xiao-yan Jiang; Hao-hong Chen; Fei-fei Cao; Lei Li; Ren-yong Lin; Hao Wen; Li Jin; Xiao-feng Wang
Journal:  Endocrine       Date:  2010-03-18       Impact factor: 3.633

5.  Association of LRP5 haplotypes with osteoporosis in Mexican women.

Authors:  Edith Falcón-Ramírez; Leonora Casas-Avila; Ricardo M Cerda-Flores; Clementina Castro-Hernández; Julieta Rubio-Lightbourn; Rafael Velázquez-Cruz; Pilar Diez-G; Rosenda Peñaloza-Espinosa; Margarita Valdés-Flores
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

6.  Moderate reduction of Norrin signaling activity associated with the causative missense mutations identified in patients with familial exudative vitreoretinopathy.

Authors:  Minghui Qin; Hiroyuki Kondo; Tomoko Tahira; Kenshi Hayashi
Journal:  Hum Genet       Date:  2007-10-23       Impact factor: 4.132

7.  Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.

Authors:  Joyce B J van Meurs; Thomas A Trikalinos; Stuart H Ralston; Susana Balcells; Maria Luisa Brandi; Kim Brixen; Douglas P Kiel; Bente L Langdahl; Paul Lips; Osten Ljunggren; Roman Lorenc; Barbara Obermayer-Pietsch; Claes Ohlsson; Ulrika Pettersson; David M Reid; Francois Rousseau; Serena Scollen; Wim Van Hul; Lidia Agueda; Kristina Akesson; Lidia I Benevolenskaya; Serge L Ferrari; Göran Hallmans; Albert Hofman; Lise Bjerre Husted; Marcin Kruk; Stephen Kaptoge; David Karasik; Magnus K Karlsson; Mattias Lorentzon; Laura Masi; Fiona E A McGuigan; Dan Mellström; Leif Mosekilde; Xavier Nogues; Huibert A P Pols; Jonathan Reeve; Wilfried Renner; Fernando Rivadeneira; Natasja M van Schoor; Kurt Weber; John P A Ioannidis; André G Uitterlinden
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

8.  Large-scale association study between two coding LRP5 gene polymorphisms and bone phenotypes and fractures in men.

Authors:  E Grundberg; E M Lau; M Lorentzon; M Lorentzson; M Karlsson; A Holmberg; L Groop; D Mellström; E Orwoll; H Mallmin; C Ohlsson; O Ljunggren; K Akesson
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

Review 9.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

10.  Association between the A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density: a meta-analysis.

Authors:  Young Ho Lee; Jin-Hyun Woo; Seong Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2008-10-19       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.